| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 9.8 | 9.4 | 7.4 |
| Other income | 0.7 | 0.2 | 0.1 |
| Total income | 10.5 | 9.6 | 7.5 |
| Profit before exceptional items & tax | 1.6 | 1.7 | 0.4 |
| Exceptional items | 0.1 | 0.0 | 0.0 |
| Profit before tax | 1.5 | 1.7 | 0.4 |
| Net profit | 1.0 | 2.0 | 0.4 |
| Operating margin | 14.3% | 17.7% | 5.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +150.00% |
|---|---|
| Net profit, quarter on quarter | -50.00% |
| Revenue, year on year | +32.40% |
Source
Read the filing ↗
BSE results filing, NSE: AUROLAB. Figures extracted from the filing.
Auro Laboratories Ltd: key numbers
- Share price
- ₹241.00
- Market cap
- ₹150.2 Cr
- Revenue (annual)
- ₹32.61 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 32.1×Sector 50.4×
- Promoter holding
- 52.40%+0.22% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Auro Laboratories Ltd
All →
19:05 IST
BSE
Financial Results
Auro Laboratories Q1 FY27 Results: Turns Profitable, Net Profit ₹1 Cr
Auro Laboratories Ltd reported revenue from operations of ₹8.8 Cr (+214.3% YoY) and net profit of ₹1 Cr for Q1 FY27.
- Key figure
- Net profit ₹1 Cr